NEW

Activ Surgical Announces FDA Clearance for ActivSight Intraoperative Imaging Module

Activ Surgical announced the U.S. Food and Drug Administration (FDA) 510(k) clearance of the company’s ActivSight Intraoperative Imaging Module for enhanced surgical visualization.

Metrex Surface Disinfectant Portfolio Secures EPA Approval

The U.S. Environmental Protection Agency (EPA) has approved all eight surface disinfectant products made by an infection prevention leader, Metrex, as effective against SARS-CoV-2, the novel coronavirus that causes COVID-19.

Olympus Supports Safety Actions Regarding Surgical Smoke

Olympus has announced its support of The Joint Commission’s recommended safety actions for managing the hazards of exposure to surgical smoke for health care staff in operating rooms.

Exofin Fusion Redesign Receives FDA Approval

Chemence Medical, a leader in medical cyanoacrylate devices and products, announced the U.S. Federal Drug Administration’s (FDA) 510(k) approval of the company’s redesigned exofin fusion skin closure system.

3M Submits 510(k) Application for BI System

3M has filed for 510(k) clearance with the U.S. Food and Drug Administration (FDA) for an additional indication for its Attest Rapid Biological Indicator (BI) System for vaporized hydrogen peroxide sterilization (VH202) to provide BI test results in just 24 minutes. Pending clearance, the 24-minute results are anticipated to be the fastest BI readout on the market for VH202 sterilization and will make the practice of every load monitoring increasingly feasible.

“Every minute counts when it comes to patient safety,” said Cindy Kent from the 3M Infection Prevention Division. “Central sterile departments deserve simple and effective solutions to help minimize the risk of healthcare acquired infections from surgical instruments. Faster BI readout times can increase feasibility to monitor every sterilization load, helping to provide ultimate confidence that every patient receives the same high standard of care.”

A 24-minute result would be a significant advancement over 3M’s current market-leading time of four hours, achieved with the 2016 release of the 3M Attest Rapid Biological Indicator System for VH202. With a continued focus on system enhancements following the 4-hour readout launch, 3M scientists were able to increase system capabilities including a faster readout time.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X